Silk Road Medical Inc SILK
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover SILK, but with our powerful screener, you can find
stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, INFN, SILK on Behalf of Shareholders
-
SILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger and Looming Vote on September 5, 2024, of Silk Road Medical, Inc.
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, BALY, K on Behalf of Shareholders
-
SILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger and Looming Vote on September 5, 2024, of Silk Road Medical, Inc.
-
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, ALIM, INFN on Behalf of Shareholders
-
SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK
-
SILK Alert: Monsey Firm of Wohl & Fruchter Renews Investigation of the Proposed Sale of Silk Road Medical to Boston Scientific
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.63
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 474
- Website
- https://www.silkroadmed.com
Comparables
Valuation
|
Metric
|
SILK
|
SIBN
|
PRCT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 7.22 | 3.70 | 14.98 |
Price/Sales | 5.63 | 3.97 | 20.74 |
Price/Cash Flow | — | — | — |
Price/Earnings
SILK
SIBN
PRCT
Financial Strength
|
Metric
|
SILK
|
SIBN
|
PRCT
|
|---|---|---|---|
Quick Ratio | 6.28 | 7.99 | 6.37 |
Current Ratio | 7.63 | 9.17 | 7.51 |
Interest Coverage | −8.63 | −12.97 | −26.05 |
Quick Ratio
SILK
SIBN
PRCT
Profitability
|
Metric
|
SILK
|
SIBN
|
PRCT
|
|---|---|---|---|
Return on Assets (Normalized) | −5.82% | −6.03% | −20.90% |
Return on Equity (Normalized) | −10.02% | −8.10% | −30.98% |
Return on Invested Capital (Normalized) | −8.00% | −8.97% | −25.33% |
Return on Assets
SILK
SIBN
PRCT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Yxtlpzyj | Xytrrm | $196.0 Bil | |||
| Stryker Corp
SYK
| Xyfqnpqr | Rpc | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Zkskvmf | Tlqhbk | $124.5 Bil | |||
| Medtronic PLC
MDT
| Bpmplbqh | Wfwvf | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Hjfcxbymq | Ptktxg | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Wny | Txvg | $30.2 Bil | |||
| DexCom Inc
DXCM
| Mkrcwddksd | Bmxl | $27.3 Bil | |||
| Steris PLC
STE
| Jbfcymd | Ksdpcys | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Tkrgcmgnfc | Nlcs | $21.3 Bil | |||
| Insulet Corp
PODD
| Wxwpvvnkn | Yvqvsh | $16.1 Bil |
United States